| |
|
|
|
AzurRx BioPharma Inc.  
|
|
1.78 0.21 (0.13%) |
06-18 15:59 |
|
Open: |
1.59 |
Pre close: |
1.57 |
Target:
|
2.59
|
|
High: |
1.795 |
Low: |
1.59 |
Resistance:
|
2.22
2.71
|
|
Volume: |
57,104 |
Market Cap: |
37M |
Support:
|
1.42
1.18
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.71
 |
MACD |
MACD(12,26):
|
-0.19  |
|
MA(20): |
2.02 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
2.23 |
Stochastic Oscillator |
%K(14,3):
|
27.14 |
|
MA(250): |
2.32 |
%D(3): |
20.20 |
|
Average Volume(K) |
3-Month: |
10387
|
52-Week |
High:
|
3.75 |
|
10-Days: |
12624 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
35.60 |
Change(%): |
-45.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-784.2 |
Shares Out. (M) |
21.06 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-212.0 |
Shares Float (M) |
20.09 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.10 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
15.600 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.28 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.89 |
P/CF |
-3.32 |
|
|
|
|
|
|
